Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study

Objective: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patient...

Full description

Bibliographic Details
Main Authors: Hui Lu, Shanshan Guo, Liting Liu, Qiuyan Chen, Yujing Liang, Sailan Liu, Xuesong Sun, Qingnan Tang, Xiaoyun Li, Ling Guo, Haoyuan Mo, Linquan Tang, Haiqiang Mai
Format: Article
Language:English
Published: China Anti-Cancer Association 2022-04-01
Series:Cancer Biology & Medicine
Subjects:
Online Access:https://www.cancerbiomed.org/content/19/4/551
_version_ 1811244996389502976
author Hui Lu
Shanshan Guo
Liting Liu
Qiuyan Chen
Yujing Liang
Sailan Liu
Xuesong Sun
Qingnan Tang
Xiaoyun Li
Ling Guo
Haoyuan Mo
Linquan Tang
Haiqiang Mai
author_facet Hui Lu
Shanshan Guo
Liting Liu
Qiuyan Chen
Yujing Liang
Sailan Liu
Xuesong Sun
Qingnan Tang
Xiaoyun Li
Ling Guo
Haoyuan Mo
Linquan Tang
Haiqiang Mai
author_sort Hui Lu
collection DOAJ
description Objective: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patients with advanced nasopharyngeal carcinoma (NPC). Methods: We retrospectively analyzed 433 patients with advanced NPC having no evidence of metastasis from January 2007 to June 2011; the patients underwent radical concurrent chemoradiotherapy (CCRT) at Sun Yat-sen University Cancer Center and were grouped based on their ΔCONUT and ΔCONUT-EBV DNA scores. Kaplan-Meier curves were used to compare the patient outcomes according to the cut-off ΔCONUT score and the ΔCONUT-EBV DNA scoring system. Results: Among all patients, overall survival (OS) was independently predicted by a high ΔCONUT score (P = 0.031) and high EBV DNA (P < 0.001). The ΔCONUT-EBV DNA score [OS area under the curve (AUC) = 0.621; progression free survival (PFS)-AUC = 0.612; distant metastasis-free survival (DMFS)-AUC = 0.622] was more predictive of OS, PFS, and DMFS in patients with advanced NPC than the ΔCONUT score (OS-AUC = 0.547; PFS-AUC = 0.533; DMFS-AUC = 0.522) and pretreatment plasma EBV DNA levels alone (OS-AUC = 0.600; PFS-AUC = 0.591, DMFS-AUC = 0.610). The ΔCONUT-EBV DNA score was significantly correlated with OS, PFS, and DMFS in patients with advanced NPC treated with CCRT. Conclusions: The ΔCONUT-EBV DNA score may be useful in clinical practice as a convenient biomarker for predicting the outcomes in patients with advanced NPC treated with CCRT.
first_indexed 2024-04-12T14:33:28Z
format Article
id doaj.art-a014f4cdf0b04744a95c7e19f0b3e457
institution Directory Open Access Journal
issn 2095-3941
language English
last_indexed 2024-04-12T14:33:28Z
publishDate 2022-04-01
publisher China Anti-Cancer Association
record_format Article
series Cancer Biology & Medicine
spelling doaj.art-a014f4cdf0b04744a95c7e19f0b3e4572022-12-22T03:29:10ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412022-04-0119455156410.20892/j.issn.2095-3941.2020.0627Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up studyHui Lu0Shanshan Guo1Liting Liu2Qiuyan Chen3Yujing Liang4Sailan Liu5Xuesong Sun6Qingnan Tang7Xiaoyun Li8Ling Guo9Haoyuan Mo10Linquan Tang11Haiqiang Mai12State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaObjective: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patients with advanced nasopharyngeal carcinoma (NPC). Methods: We retrospectively analyzed 433 patients with advanced NPC having no evidence of metastasis from January 2007 to June 2011; the patients underwent radical concurrent chemoradiotherapy (CCRT) at Sun Yat-sen University Cancer Center and were grouped based on their ΔCONUT and ΔCONUT-EBV DNA scores. Kaplan-Meier curves were used to compare the patient outcomes according to the cut-off ΔCONUT score and the ΔCONUT-EBV DNA scoring system. Results: Among all patients, overall survival (OS) was independently predicted by a high ΔCONUT score (P = 0.031) and high EBV DNA (P < 0.001). The ΔCONUT-EBV DNA score [OS area under the curve (AUC) = 0.621; progression free survival (PFS)-AUC = 0.612; distant metastasis-free survival (DMFS)-AUC = 0.622] was more predictive of OS, PFS, and DMFS in patients with advanced NPC than the ΔCONUT score (OS-AUC = 0.547; PFS-AUC = 0.533; DMFS-AUC = 0.522) and pretreatment plasma EBV DNA levels alone (OS-AUC = 0.600; PFS-AUC = 0.591, DMFS-AUC = 0.610). The ΔCONUT-EBV DNA score was significantly correlated with OS, PFS, and DMFS in patients with advanced NPC treated with CCRT. Conclusions: The ΔCONUT-EBV DNA score may be useful in clinical practice as a convenient biomarker for predicting the outcomes in patients with advanced NPC treated with CCRT.https://www.cancerbiomed.org/content/19/4/551controlling nutritional status scoreepstein-barr virus deoxyribonucleic acidnasopharyngeal carcinomaprognosispredictive factor
spellingShingle Hui Lu
Shanshan Guo
Liting Liu
Qiuyan Chen
Yujing Liang
Sailan Liu
Xuesong Sun
Qingnan Tang
Xiaoyun Li
Ling Guo
Haoyuan Mo
Linquan Tang
Haiqiang Mai
Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
Cancer Biology & Medicine
controlling nutritional status score
epstein-barr virus deoxyribonucleic acid
nasopharyngeal carcinoma
prognosis
predictive factor
title Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
title_full Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
title_fullStr Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
title_full_unstemmed Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
title_short Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
title_sort prognostic significance of a combined and controlled nutritional status score and ebv dna in patients with advanced nasopharyngeal carcinoma a long term follow up study
topic controlling nutritional status score
epstein-barr virus deoxyribonucleic acid
nasopharyngeal carcinoma
prognosis
predictive factor
url https://www.cancerbiomed.org/content/19/4/551
work_keys_str_mv AT huilu prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT shanshanguo prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT litingliu prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT qiuyanchen prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT yujingliang prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT sailanliu prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT xuesongsun prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT qingnantang prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT xiaoyunli prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT lingguo prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT haoyuanmo prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT linquantang prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy
AT haiqiangmai prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy